Autolus Therapeutics (ADR)
Commercializes AUCATZYL while developing programmed T-cell therapies for cancer and autoimmune diseases.
$2.34
After-hours close+0.01 (+0.43%)
At close$2.33(−1.27%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 50.51%134.44M sharesInsiders 0.53%1.41M sharesOther 48.96%130.29M shares
Shares outstanding 266.14M · Float 240.52M · 90.4% free float
Institutions13F, as of Mar 31, 2026
87 holders · 134.44M shares · 9 new positions · 34 increased · 27 reduced · 14 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Mak Capital One LLC | 33.62M | 12.63% | +3.62M | May 15, 2026 |
| Blackstone Inc. | 20.49M | 7.70% | 0 | May 15, 2026 |
| Syncona Portfolio Ltd | 16.64M | 6.25% | 0 | May 14, 2026 |
| Armistice Capital, LLC | 15.80M | 5.94% | −1.70M | May 15, 2026 |
| TFG Asset Management GP Ltd | 9.50M | 3.57% | 0 | May 15, 2026 |
| Schroder Investment Management Group | 9.49M | 3.57% | 0 | May 14, 2026 |
| Frazier Life Sciences Management, L.P. | 4.45M | 1.67% | −175.4K | May 15, 2026 |
| BNP Paribas Asset Management Holding S.A. | 3.36M | 1.26% | 0 | May 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| MAK Capital Fund LP | 12.60% | 33.62M | 13G | May 15, 2026 ↗ |
| Syncona Portfolio Limited | 10.80% | 28.82M | 13G | May 7, 2025 ↗ |
| Wellington Investment Advisors Holdings LLPincl. Wellington Management Company LLP, Wellington Management Group LLP +1 more | 9.11% | 24.22M | 13G | Nov 8, 2024 ↗ |
| Armistice Capital, LLC | 5.94% | 15.80M | 13G | May 15, 2026 ↗ |
| PPF IM Ltd.incl. Renata Kellnerova, PPF Group a.s. +1 more | 5.60% | 14.78M | 13D | Aug 28, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Christian Itin | director, officer: Chief Executive Officer | 1.12M | 0.42% | Mar 18, 2026 |
| Christopher Andrew Vann | officer: Chief Operating Officer | 152.2K | 0.06% | Mar 18, 2026 |
| John E. Berriman | director | 136.3K | 0.05% | Mar 18, 2026 |
| Christopher Michael James Williams | officer: Chief Business Officer | 8.2K | 0.00% | Mar 18, 2026 |
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.